Showing 1 - 1 results of 1 for search 'Josep Redón', query time: 0.02s Refine Results
  1. 1
    Cardiovascular risk reduction by reversing endothelial dysfunction: ARBs, ACE inhibitors,  or both? Expectations from The ONTARGET  Trial Programme

    Cardiovascular risk reduction by reversing endothelial dysfunction: ARBs, ACE inhibitors,  or both? Expectations from The ONTARGET  Trial Programme by Luis Miguel  Ruilope, Josep Redón, Rol, Schmieder

    Published 2007-03-01
    Get full text
    Article

Search Tools: